Connection

John Colwell to Diabetes Mellitus

This is a "connection" page, showing publications John Colwell has written about Diabetes Mellitus.
Connection Strength

2.170
  1. Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethn Dis. 2008; 18(2):131-5.
    View in: PubMed
    Score: 0.204
  2. Is aspirin effective in diabetic patients? Yes. J Thromb Haemost. 2005 Dec; 3(12):2612-4.
    View in: PubMed
    Score: 0.176
  3. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3.
    View in: PubMed
    Score: 0.154
  4. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8.
    View in: PubMed
    Score: 0.149
  5. Aspirin therapy in diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S87-8.
    View in: PubMed
    Score: 0.144
  6. Hemoglobin A1c is not the only issue. Curr Diab Rep. 2002 Aug; 2(4):295-6.
    View in: PubMed
    Score: 0.140
  7. Treatment for the procoagulant state in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):1011-30.
    View in: PubMed
    Score: 0.133
  8. New legislation covers reimbursement and diabetes care guidelines. J S C Med Assoc. 2000 Sep; 96(9):382-5.
    View in: PubMed
    Score: 0.122
  9. Aspirin and risk of hemorrhagic stroke. JAMA. 1999 Aug 25; 282(8):731-2; author reply 732-3.
    View in: PubMed
    Score: 0.114
  10. Overview of the Diabetes Initiative of South Carolina. J S C Med Assoc. 1998 Nov; 94(11):468-72.
    View in: PubMed
    Score: 0.108
  11. Preventive care among people with diabetes in biracial population. J S C Med Assoc. 1997 Dec; 93(12):443-7.
    View in: PubMed
    Score: 0.101
  12. Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71.
    View in: PubMed
    Score: 0.101
  13. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402.
    View in: PubMed
    Score: 0.060
  14. President's address. Diabetes. 1988 Nov; 37(11):1449-52.
    View in: PubMed
    Score: 0.054
  15. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6.
    View in: PubMed
    Score: 0.044
  16. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes. 1983 Jan; 32(1):20-5.
    View in: PubMed
    Score: 0.036
  17. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia. 1982 Jun; 22(6):430-6.
    View in: PubMed
    Score: 0.035
  18. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8.
    View in: PubMed
    Score: 0.031
  19. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6.
    View in: PubMed
    Score: 0.030
  20. Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 1979 Apr; 28(4 Suppl 1):394-400.
    View in: PubMed
    Score: 0.028
  21. Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8.
    View in: PubMed
    Score: 0.027
  22. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease. Metabolism. 1977 Mar; 26(3):279-85.
    View in: PubMed
    Score: 0.024
  23. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31.
    View in: PubMed
    Score: 0.022
  24. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus. Diabetes. 1975 Jul; 24(7):684-7.
    View in: PubMed
    Score: 0.021
  25. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10.
    View in: PubMed
    Score: 0.017
  26. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug; 16(8):560-5.
    View in: PubMed
    Score: 0.012
  27. Effect of diabetic control on retinopathy. Diabetes. 1966 Jul; 15(7):497-9.
    View in: PubMed
    Score: 0.011
  28. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Haemostasis. 1986; 16(6):433-8.
    View in: PubMed
    Score: 0.011
  29. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.010
  30. QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS. Diabetes. 1963 Sep-Oct; 12:424-8.
    View in: PubMed
    Score: 0.009
  31. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes. 1981 Jul; 30(7):575-9.
    View in: PubMed
    Score: 0.008
  32. Atherosclerosis in diabetes mellitus. J Chronic Dis. 1981; 34(1):1-4.
    View in: PubMed
    Score: 0.008
  33. Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thromb Res. 1980 Jan 1-15; 17(1-2):261-6.
    View in: PubMed
    Score: 0.007
  34. A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71.
    View in: PubMed
    Score: 0.006
  35. The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects. Clin Endocrinol (Oxf). 1977 Jun; 6(6):437-42.
    View in: PubMed
    Score: 0.006
  36. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun; 82(6):733-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.